Search results: Sage Journals

Restricted accessResearch articleFirst published May, 2018

Outcomes and Challenges of A PD-First Program,A South-African Perspective

Bianca Davidson, Kenneth Crombie, Kathryn Manning [...]

Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis

Restricted accessResearch articleFirst published April, 2023

A retrospective analysis of first-line PD-1 monoclonal antibodies treatment in patients with leptomeningeal metastasis from solid tumors

Zhaohui Chu, Hao Lin, Qiong Zhan [...]

Journal of Oncology Pharmacy Practice

Restricted accessResearch articleFirst published January, 2023

Time-dependent incidence rates and risk factors for transferring to hemodialysis in patients on peritoneal dialysis under the Thai PD-First Policy

Pornpen Sangthawan, Thammasin Ingviya, Nintita Sripaiboonkit Thokanit [...]

Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis

Restricted accessResearch articleFirst published October, 2009

The PD First Breakthrough Initiative – “Clinical Benefits of PD First”

Maurizio Gallieni

The Journal of Vascular Access

Open accessResearch articleFirst published 2023

Efficacy and safety of first-line PD-1/PD-L1 inhibitor combinations for extensive-stage small-cell lung cancer: a Bayesian network meta-analysis

Huijuan Li, Hedong Han, Chuling Li [...]

Therapeutic Advances in Medical Oncology

Restricted accessResearch articleFirst published December, 2022

Is There a Role for Pneumatic Dilation in Primary Treatment of Achalasia? Pro: PD Should Always the First Choice for Achalasia Treatment.

Marta Arjonilla, Alexandra Guillaume

Foregut: The Journal of the American Foregut Society

Restricted accessResearch articleFirst published May, 2018

Survival Analysis and Associated Factors in THAI Patients on Peritoneal Dialysis under the PD-First Policy

Siribha Changsirikulchai, Suwannee Sriprach, Nintita Sripaiboonkij Thokanit [...]

Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis

Open accessResearch articleFirst published 2023

Comparison of the profiles of first-line PD-1/PD-L1 inhibitors for advanced NSCLC lacking driver gene mutations: a systematic review and Bayesian network meta-analysis

Fu Wenfan, Xu Manman, Shi Xingyuan [...]

Sage Open Chronic Disease

Restricted accessResearch articleFirst published June, 2007

Development of the “Peritoneal Dialysis First” Model in Hong Kong

Alex Wai-Yin Yu, Ka-Foon Chau, Yiu-Wing Ho [...]

Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis

Restricted accessArticle commentaryFirst published July, 2021

The cost-effectiveness of atezolizumab in first-line for metastatic triple negative breast cancer is heavily linked to PD-L1 level

Jacopo Giuliani, Beatrice Mantoan, Andrea Bonetti

Journal of Oncology Pharmacy Practice

Restricted accessResearch articleFirst published May, 2018

Outcomes and Challenges of A PD-First Program,A South-African Perspective

Bianca Davidson, Kenneth Crombie, Kathryn Manning [...]

Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis

Restricted accessResearch articleFirst published April, 2023

A retrospective analysis of first-line PD-1 monoclonal antibodies treatment in patients with leptomeningeal metastasis from solid tumors

Zhaohui Chu, Hao Lin, Qiong Zhan [...]

Journal of Oncology Pharmacy Practice

Restricted accessResearch articleFirst published January, 2023

Time-dependent incidence rates and risk factors for transferring to hemodialysis in patients on peritoneal dialysis under the Thai PD-First Policy

Pornpen Sangthawan, Thammasin Ingviya, Nintita Sripaiboonkit Thokanit [...]

Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis

Restricted accessResearch articleFirst published October, 2009

The PD First Breakthrough Initiative – “Clinical Benefits of PD First”

Maurizio Gallieni

The Journal of Vascular Access

Open accessResearch articleFirst published 2023

Efficacy and safety of first-line PD-1/PD-L1 inhibitor combinations for extensive-stage small-cell lung cancer: a Bayesian network meta-analysis

Huijuan Li, Hedong Han, Chuling Li [...]

Therapeutic Advances in Medical Oncology

Restricted accessResearch articleFirst published December, 2022

Is There a Role for Pneumatic Dilation in Primary Treatment of Achalasia? Pro: PD Should Always the First Choice for Achalasia Treatment.

Marta Arjonilla, Alexandra Guillaume

Foregut: The Journal of the American Foregut Society

Restricted accessResearch articleFirst published May, 2018

Survival Analysis and Associated Factors in THAI Patients on Peritoneal Dialysis under the PD-First Policy

Siribha Changsirikulchai, Suwannee Sriprach, Nintita Sripaiboonkij Thokanit [...]

Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis

Open accessResearch articleFirst published 2023

Comparison of the profiles of first-line PD-1/PD-L1 inhibitors for advanced NSCLC lacking driver gene mutations: a systematic review and Bayesian network meta-analysis

Fu Wenfan, Xu Manman, Shi Xingyuan [...]

Sage Open Chronic Disease

Restricted accessResearch articleFirst published June, 2007

Development of the “Peritoneal Dialysis First” Model in Hong Kong

Alex Wai-Yin Yu, Ka-Foon Chau, Yiu-Wing Ho [...]

Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis

Restricted accessArticle commentaryFirst published July, 2021

The cost-effectiveness of atezolizumab in first-line for metastatic triple negative breast cancer is heavily linked to PD-L1 level

Jacopo Giuliani, Beatrice Mantoan, Andrea Bonetti

Journal of Oncology Pharmacy Practice